Nexentis Technologies Inc (NASDAQ:NXTS) shares are trending on Monday.
NXTS shares surged 155.91% during Monday’s regular trading session to close at $13.00.
However, the stock fell sharply in after-hours trading, dropping 46.15% to $7.00.
Nexentis Technologies is a biotech company that owns MitoCareX Bio, a drug discovery company focused on developing treatments for cancer and inflammatory metabolic diseases.
The company also invests in solar energy projects in Europe through its Ready-to-Build (RTB) investment model.






